Stay updated on BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial

Sign up to get notified when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of a Phase 1/2 clinical trial involving BBI608 administered in combination with immune checkpoint inhibitors for adult patients with advanced cancers.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:42.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying both inclusion and exclusion criteria, as well as general information about clinical research and the importance of informed consent.
    Difference
    42%
    Check dated 2024-05-22T20:56:12.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:18:25.000Z thumbnail image

Stay in the know with updates to BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.